UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
2 in 10 Korean doctors dissatisfied with their job
Less than half of Korean doctors are satisfied with their jobs with 20 perc...
by Marian Chu
|
2017-04-19 19:29
라인
How many Korean medical theses ranked in world’s top 1%
Korea has been ranked at the 15 place in the world by having about 3,600 me...
by Nam Doo-hyun
|
2017-04-19 18:42
라인
Daewoong launches first generic antibiotic in US
Daewoong Pharmaceutical대웅제약 has launched its generic antibiotic “Meropenem”...
by Constance Williams
|
2017-04-19 18:03
라인
'Erase your father’s shadow': Dong-A, Daewoong, JW Pharmaceutical, Jeil
Chairman Kang Jung-seok of Dong-A Socio Group; deep shade of ‘godfather’ an...
by Lee Hye-seon
|
2017-04-19 16:35
라인
NHIS under fire for lax management of employee loans
Koreans have long called state enterprises and public corporations “gods’ w...
by Marian Chu
|
2017-04-18 18:30
라인
Some pharmacies stick to tobacco sale despite public criticism
“Give the disease and offer the remedy,” an old Korean saying goes, which i...
by Constance Williams
|
2017-04-18 16:54
라인
State auditors ‘fail to confirm Hanmi’s cover-up of clinical results’
The government’s top administrative watchdog has found Hanmi Pharmaceutical...
by Marian Chu
|
2017-04-18 15:23
라인
‘We must move beyond completely curing Hepatitis C to eradicating it’
From the end of 2015 to 2016, mass infections of hepatitis C occurred at th...
by Park Gi-taek
|
2017-04-18 14:47
라인
FDA stuns Eli-Lilly, Incyte by rejecting rheumatoid arthritis drug
Eli Lilly and Co. and Incyte Corp. said Friday that the U.S. Food and Drug ...
by Constance Williams
|
2017-04-17 17:17
라인
Will post-mass infection anti-HCV measures prove to be sufficient?
From the end of 2015 to 2016, mass infections of hepatitis C occurred at th...
by Park Gi-taek
|
2017-04-17 16:49
라인
Cancer patients protest against Novartis Korea
Novartis Korea’s targeted anticancer treatment, Gleevec, is in danger of lo...
by Marian Chu
|
2017-04-17 15:04
라인
Australian CEO stresses significant role of digital healthcare
Modern, efficient data management not only benefits doctors and patients in...
by Constance Williams
|
2017-04-17 11:57
라인
WWII sex slaves – and their children – suffer from lifelong trauma
Korean sex slaves, forced into prostitution at Japanese military brothels d...
by Marian Chu
|
2017-04-17 11:06
라인
Hanyang U symposium on rheumatism set for May 18
Hanyang University Hospital will hold its annual international symposium on...
by Constance Williams
|
2017-04-17 10:41
라인
Management by brothers put to test: Hanmi, Green Cross
As major pharmaceutical companies announced personnel appointments early th...
by Lee Hye-seon
|
2017-04-14 18:29
라인
Korean firms stage ‘let’s-save-our drug’ drive
The “let’s-save-our drug” campaign -- initiated by the domestic medicine di...
by Lee Hye-seon
|
2017-04-14 15:30
라인
Sewol ferry survivors struggle with PTSD
The survivors of the Sewol ferry disaster and the bereaved family members o...
by Marian Chu
|
2017-04-14 10:33
라인
Surge of ‘princess' surgery’ tells much about gender roles
“Are you married? Did you get an abortion? A lot of young people who’ve had...
by Marian Chu
|
2017-04-13 19:06
라인
Workshop discusses ‘personalized medicine’ in depth
Korean and Italian pathological experts agreed on the need Tuesday for maki...
by Constance Williams
|
2017-04-13 17:27
라인
Insurance coverage of immunotherapeutic anticancer drug gains momentum
Much to the relief of cancer patients, the moves toward the insurance cover...
by Park Gi-taek
|
2017-04-13 16:50
-
이전
321
322
323
324
325
326
327
328
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top